We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Intelerad

Intelerad Medical Systems offers medical imaging PACS and cross-enterprise workflow solutions for imaging providers r... read more Featured Products: More products

Download Mobile App




Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings

By HospiMedica International staff writers
Posted on 22 Jun 2019
Intelerad Medical Systems (Montreal, Canada), a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.

Intelerad’s technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient. More...
On a daily basis, Intelerad’s solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide.

With an emphasis on cloud technology and artificial intelligence, Intelerad is focused on providing innovative Software as a Service (SaaS) solutions for healthcare. For example, the company’s cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher quality, more timely care and better outcomes for patients. The company’s USD 75 million investment and ongoing focus on creating innovative, market-leading solutions for a global customer base are expected to fuel a two-fold increase in study volume.

“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution,” said Mr. Paul Lepage, President and CEO of Intelerad. “We are proud to support customers around the world in providing the highest standard of healthcare services. We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients.”



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.